AR039983A1 - DERIVATIVES OF HETROXI TETRAHIDRO-NAFTALENILUREA - Google Patents

DERIVATIVES OF HETROXI TETRAHIDRO-NAFTALENILUREA

Info

Publication number
AR039983A1
AR039983A1 ARP030101614A ARP030101614A AR039983A1 AR 039983 A1 AR039983 A1 AR 039983A1 AR P030101614 A ARP030101614 A AR P030101614A AR P030101614 A ARP030101614 A AR P030101614A AR 039983 A1 AR039983 A1 AR 039983A1
Authority
AR
Argentina
Prior art keywords
alkyl
halogen
amino
optionally substituted
tri
Prior art date
Application number
ARP030101614A
Other languages
Spanish (es)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of AR039983A1 publication Critical patent/AR039983A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Abstract

Se refiere a derivados de tetrahidronaftaleno y a sales de los mismos que son útiles como ingredientes activos de preparaciones farmacéuticas. Los derivados de tetrahidro-naftaleno de la presente tienen una excelente actividad como antagonistas de VR1 y son útiles para la profilaxis y tratamiento de enfermedades asociadas con la actividad de VR1, en particular para el tratamiento de la imperiosidad urinaria, vejiga superactiva, dolor crónico, dolor neuropático, dolor postoperatorio, dolor de artritis reumatoide, neuralgia, neuropatías, algesia, lesión de nervios, isquemia, neurodegeneración, apoplejía, incontinencia, trastornos inflamatorios tales como asma y COPD. Reivindicación 1: Un derivado de hidroxi-tetrahidro-naftalenilurea de fórmula (1), sus formas tautomérica y estereoisomérica y las sales del mismo en la que: X representa alquilo C1-6, o un grupo de fórmula (2); donde: Y representa un enlace directo, o un grupo de fórmula (3), R1, R2 y R3 representan independientemente hidrógeno, halógeno, hidroxi, nitro, carboxi, amino, alquil(C1-6)-amino di(alquil)amino, cicloalquil(C3-8)-amino, alcoxi(C1-6)-carbonilo, fenilo, bencilo, sulfonamida, alcanoilo C1-6, -amino, carbamoilo, alquil(C1-6)-carbamoilo, ciano, alquilo C1-6 opcionalmente sustituido con ciano, alcoxi(C1-6)carbonilo mono-, di- o tri-halógeno, alcoxi C1-6 opcionalmente sustituido con mono-, di- o tri-halógeno, fenoxi opcionalmente sustituido con halógeno o alquilo C1-6, o alquiltio C1-6 opcionalmente sustituido con mono-, di- o tri-halógeno; R4, R5, R5, R6 y R7 representan independientemente hidrógeno, alquilo C1-6 o fenilo; Z1 representa hidrógeno o alquilo C1-6; y Z2 representa hidrógeno, halógeno o alquilo C1-6.It refers to tetrahydronaphthalene derivatives and salts thereof that are useful as active ingredients in pharmaceutical preparations. The tetrahydro-naphthalene derivatives herein have excellent activity as VR1 antagonists and are useful for the prophylaxis and treatment of diseases associated with the activity of VR1, in particular for the treatment of urinary empire, superactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritis pain, neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, stroke, incontinence, inflammatory disorders such as asthma and COPD. Claim 1: A hydroxy-tetrahydro-naphthalenylurea derivative of formula (1), its tautomeric and stereoisomeric forms and salts thereof wherein: X represents C1-6 alkyl, or a group of formula (2); where: Y represents a direct bond, or a group of formula (3), R1, R2 and R3 independently represent hydrogen, halogen, hydroxy, nitro, carboxy, amino, (C1-6) alkyl-amino di (alkyl) amino, C3-8 cycloalkyl-amino, (C 1-6) alkoxycarbonyl, phenyl, benzyl, sulfonamide, C 1-6 alkanoyl, -amino, carbamoyl, (C 1-6) alkylcarbamoyl, cyano, C 1-6 alkyl optionally substituted with cyano, (C1-6) alkoxy mono-, di- or tri-halogen, C1-6 alkoxy optionally substituted with mono-, di- or tri-halogen, phenoxy optionally substituted with halogen or C1-6 alkyl, or C1-6 alkylthio optionally substituted with mono-, di- or tri-halogen; R4, R5, R5, R6 and R7 independently represent hydrogen, C1-6 alkyl or phenyl; Z1 represents hydrogen or C1-6 alkyl; and Z2 represents hydrogen, halogen or C1-6 alkyl.

ARP030101614A 2002-05-08 2003-05-08 DERIVATIVES OF HETROXI TETRAHIDRO-NAFTALENILUREA AR039983A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210512.0A GB0210512D0 (en) 2002-05-08 2002-05-08 Tetrahydro-napthalene derivatives
GBGB0227262.3A GB0227262D0 (en) 2002-05-08 2002-11-21 Tetrahydro-naphthalene derivatives

Publications (1)

Publication Number Publication Date
AR039983A1 true AR039983A1 (en) 2005-03-09

Family

ID=9936269

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101614A AR039983A1 (en) 2002-05-08 2003-05-08 DERIVATIVES OF HETROXI TETRAHIDRO-NAFTALENILUREA

Country Status (13)

Country Link
KR (1) KR101000688B1 (en)
AR (1) AR039983A1 (en)
CU (1) CU23422B7 (en)
DO (1) DOP2003000642A (en)
EC (1) ECSP045413A (en)
GB (2) GB0210512D0 (en)
GT (1) GT200300102A (en)
MA (1) MA30728B1 (en)
MY (1) MY155011A (en)
PE (1) PE20040363A1 (en)
PT (1) PT1506167E (en)
UA (1) UA77301C2 (en)
ZA (1) ZA200408993B (en)

Also Published As

Publication number Publication date
KR20040108784A (en) 2004-12-24
PE20040363A1 (en) 2004-07-03
ECSP045413A (en) 2005-01-03
DOP2003000642A (en) 2003-11-15
KR101000688B1 (en) 2010-12-10
PT1506167E (en) 2007-12-10
GB0227262D0 (en) 2002-12-31
MA30728B1 (en) 2009-10-01
GT200300102A (en) 2004-03-17
MY155011A (en) 2015-08-28
UA77301C2 (en) 2006-11-15
GB0210512D0 (en) 2002-06-19
ZA200408993B (en) 2006-01-25
CU23422B7 (en) 2009-09-08

Similar Documents

Publication Publication Date Title
CR8649A (en) FORMAMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
PA8621901A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
DOP2010000148A (en) BIS- (SULFONILZMINO) DERIVATIVES IN THERAPY 066
ECSP045476A (en) THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS MEDICATIONS
CL2023001738A1 (en) prmt5 inhibitors
PA8557501A1 (en) BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS
GT200200272A (en) FORMS OF SALT E-2-METOXI-N- (3- {4- [3-METHYL-4- (6-METHYLPIRIDIN-3-ILOXI) PHENYLAMINE] QUINAZOLIN-6-IL} ALIL) ACETAMID AND PROCEDURE FOR PRODUCTION
UY27872A1 (en) CASPASA INHIBITORS AND USES OF THE SAME.
PA8604301A1 (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
DOP2003000565A (en) ESTERES HYDROXAMATE OF ACID N- (SUBSTITUTED 4-PHENYL) - ANTRANILICO
EA201070619A1 (en) CARBOXAMIDE, SULPHONAMIDE AND AMINE COMPOUNDS FROM METABOLIC DISORDERS
HN2003000039A (en) 2- (PIRIMIDIN-2-ILAMINO) -PIRIDO [2,3-d] PIRIMIDIN-7-ONAS
HK1082946A1 (en) Hydroxy tetrahydro-naphthalenyurea derivatives
DE60315704D1 (en) Tetrahydronaphthalene DERIVATIVES
PE20060796A1 (en) PROCEDURE TO INTENSIFY THE EFFICIENCY OF ETABOXAM
PA8603001A1 (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
CR9183A (en) METAS REPLACED THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
CL2022001741A1 (en) Cyclic compounds and methods of using same
CL2020001420A1 (en) Procedure for the preparation of (3s) -3- (4-chloro-3 - {[(2s, 3r) -2- (4-chlorophenyl) -4,4,4-trifluoro-3-methylbutanoyl] amino} phenyl) -3-cyclopropylpropanoic acid and its crystalline form for use as an active pharmaceutical ingredient.
DK1572632T3 (en) Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
UY28993A1 (en) TETRAHYDROISOQUINOLINAS REPLACED IN QUALITY OF MPM INHIBITORS, PROCEDURE FOR USE AS A MEDICINAL PRODUCT.-
AR039983A1 (en) DERIVATIVES OF HETROXI TETRAHIDRO-NAFTALENILUREA
ECSP20080272A (en) THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IgE
UY27794A1 (en) DERIVATIVES OF HETROXI TETRAHIDRO-NAFTALENILUREA
CO6300849A2 (en) COMPOUND (R) -N * 6 * -ETIL-6,7-DIHIDRO-5H-INDENO (5,6-D) TIAZOL-2,6-DIAMINE AND ITS USE AS ANTIPSYCHOTIC

Legal Events

Date Code Title Description
FG Grant, registration